Table of Contents Author Guidelines Submit a Manuscript
Advances in Medicine
Volume 2016 (2016), Article ID 9131680, 4 pages
http://dx.doi.org/10.1155/2016/9131680
Clinical Study

Changes of Nitric Oxide and Peroxynitrite Serum Levels during Drug Therapy in Patients with Obsessive-Compulsive Disorder

1School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Education Development Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Received 22 April 2016; Revised 27 August 2016; Accepted 27 September 2016

Academic Editor: Gianfranco Spalletta

Copyright © 2016 Leila Kouti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objectives. Some studies have shown that increased nitric oxide (NO) concentrations may be associated with obsessive-compulsive disorder (OCD). In a few animal researches, enhanced synthesis of NO had reversed the effect of selective serotonin reuptake inhibitors (SSRIs). The present study tries to find the effect of treatment with SSRIs on NO serum levels and its product peroxynitrite. Patients and Methods. Patients diagnosed with OCD who are candidates of receiving SSRIs entered this study. Two blood samples were taken from subjects, prior to drug therapy and after the patients had shown some improvements due to their regimen. Serum NO and peroxynitrite levels were measured and their correlation with SSRI use was assessed. Results. 31 patients completed this study. Mean concentrations of NO and peroxynitrite prior to drug therapy were and μmol/L, respectively. These values were 18. and μmol/L at the second blood test. With values < 0.05, these differences were considered significant. Conclusion. Patients, who showed improvement of OCD symptoms after a mean duration of SSRI monotherapy of months, had lower values of NO and peroxynitrite in their sera compared to their levels prior to therapy. Such results can be helpful in finding a predictive factor of response to therapy and augmentation therapy with future drugs that target NO synthesis.